Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-Daniel Abraham is active.

Publication


Featured researches published by Jean-Daniel Abraham.


Journal of Virology | 2002

Comparative Vaccine Studies in HLA-A2.1-Transgenic Mice Reveal a Clustered Organization of Epitopes Presented in Hepatitis C Virus Natural Infection

Nourredine Himoudi; Jean-Daniel Abraham; Anne Fournillier; Yu Chun Lone; Aurélie Joubert; Anne Op De Beeck; Delphine Freida; François A. Lemonnier; Marie Paule Kieny; Geneviève Inchauspé

ABSTRACT A polyepitopic CD8+-T-cell response is thought to be critical for control of hepatitis C virus (HCV) infection. Using transgenic mice, we analyzed the immunogenicity and dominance of most known HLA-A2.1 epitopes presented during infection by using vaccines that carry the potential to enter clinical trials: peptides, DNA, and recombinant adenoviruses. The vaccines capacity to induce specific cytotoxic T lymphocytes and interferon gamma-producing cells revealed that immunogenic epitopes are clustered in specific antigens. For two key antigens, flanking regions were shown to greatly enhance the scope of epitope recognition, whereas a DNA-adenovirus prime-boost vaccination strategy augmented epitope immunogenicity, even that of subdominant ones. The present study reveals a clustered organization of HCV immunogenic HLA.A2.1 epitopes and strategies to modulate their dominance.


Archives of Virology | 2004

HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines

Samila Siavoshian; Jean-Daniel Abraham; Marie Paule Kieny; Catherine Schuster

Summary.Several reports have shown that activity and/or expression of p53 can be modulated by Hepatitis C virus (HCV) proteins and may interfere with normal regulation of cell growth. In order to understand the relationship between p53 function and HCV proteins expression, we have investigated potential effects of the core, NS3, NS5A and NS5B proteins on Huh-7 (p53 +/+) and Hep3B (p53 −/−) cell proliferation.The effect of HCV proteins transiently expressed after recombinant-adenoviral infection was analyzed by Western blot, crystal violet and propidium iodide staining.Expression of the core, NS3, NS5A or NS5B proteins inhibited cell proliferation and blocked both cell lines in the G2/M phase of the cell cycle. c-myc and p53 expression were respectively induced and increased in Huh-7 cells only following expression of the Core protein. No expression of p21waf1/cip1 could be detected and expression of cyclin A, cdk2 and p27Kip1 were independent of HCV protein’s expression.Our results show that the effect of core, NS3, NS5A and NS5B on cell proliferation is independent of p53 expression and that only the Core protein, induces the expression of both c-myc and p53.


Vaccine | 2004

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

Jean-Daniel Abraham; Nourredine Himoudi; Francois Kien; Jean-Luc Berland; Audrey Codran; Birke Bartosch; Thomas Baumert; Glaucia Paranhos-Baccala; Catherine Schuster; Geneviève Inchauspé; Marie Paule Kieny


Archive | 2004

Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof

Anne Fournillier; Geneviève Inchauspé; Jean-Daniel Abraham; Maria Dimitrova-Tchomakov; Marie Parnot


Journal of General Virology | 2003

Analysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteins.

Francois Kien; Jean-Daniel Abraham; Catherine Schuster; Marie Paule Kieny


Archive | 2011

COMPOSITION CONTAINING THE POLYPROTEIN NS3/NS4 AND THE POLYPEPTIDE NS5B OF HCV, EXPRESSION VECTORS COMPRISING CORRESPONDING NUCLEIC SEQUENCES AND THE THERAPEUTIC APPLICATION THEREOF

Anne Fournillier; Geneviève Inchauspé; Jean-Daniel Abraham; Maria Dimitrova-Tchomakov; Marie Parnot


Archive | 2004

Composición que comprende la poliproteína ns3/ns4 y el polipéptido ns5b del vhc, vectores de expresión que incluyen las secuencias nucleicas correspondientes y utilización en terapéutica.

Jean-Daniel Abraham; Maria Dimitrova-Tchomakov; Anne Fournillier; Geneviève Inchauspé; Marie Parnot


Archive | 2004

Hcv-polyprotein ns3/ns4 und hcv-polypeptid ns5b enthaltende komposition, entsprechende nukleinsequenzen umfassende expressionsvektoren und therapeutische anwendung davon Containing HCV polyprotein-ns3 / ns4 and NS5B HCV polypeptide composition, corresponding nucleic sequences comprehensive expression vectors and therapeutic application thereof

Anne Fournillier; Geneviève Inchauspé; Jean-Daniel Abraham; Maria Dimitrova-Tchomakov; Marie Parnot


Archive | 2004

Hcv-polyprotein ns3/ns4 und hcv-polypeptid ns5b enthaltende komposition, entsprechende nukleinsequenzen umfassende expressionsvektoren und therapeutische anwendung davon

Anne Fournillier; Geneviève Inchauspé; Jean-Daniel Abraham; Maria Dimitrova-Tchomakov; Marie Parnot


Archive | 2004

Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique

Anne Fournillier; Geneviève Inchauspé; Jean-Daniel Abraham; Maria Dimitrova-Tchomakov; Marie Parnot

Collaboration


Dive into the Jean-Daniel Abraham's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Geneviève Inchauspé

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nourredine Himoudi

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge